Safety and efficacy of dual therapy with GSK233705 and salmeterol versus monotherapy with salmeterol, tiotropium, or placebo in a crossover pilot study in partially reversible COPD patients

Safety and efficacy of dual therapy with GSK233705 and salmeterol versus monotherapy with salmeterol, tiotropium, or placebo in a crossover pilot study in partially reversible COPD patients

Jutta Beier1, Jan van Noord2, Amanda Deans3, Jean Brooks3, Claire Maden3, Suus Baggen4, Rashmi Mehta5, Anthony Cahn31INSAF Respiratory Research Institute, Germany; 2Atrium Medisch Centrum, The Netherlands; 3GlaxoSmithKline, Stockley Park, UK; 4GlaxoSmithKline, Zeist, The Netherlands; 5GlaxoSmithKlin...

Full description

Bibliographic Details
Main Authors: Brooks J, Deans A, Beier J, van Noord J, Cahn A, Mehta R, Baggen S, Maden C
Format: Article
Language:English
Published: Dove Medical Press 2012-03-01
Series:International Journal of COPD
Online Access:http://www.dovepress.com/safety-and-efficacy-of-dual-therapy-with-gsk233705-and-salmeterol-vers-a9397

Internet

http://www.dovepress.com/safety-and-efficacy-of-dual-therapy-with-gsk233705-and-salmeterol-vers-a9397

Similar Items